Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
11%
Ph phase_4
4
44%
Ph not_applicable
2
22%
Ph phase_3
2
22%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(2)
Other(2)

Detailed Status

Active, not recruiting2
unknown2
Completed2
Enrolling by invitation1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 44 (44.4%)
N/A2 (22.2%)

Trials by Status

enrolling_by_invitation111%
not_yet_recruiting111%
active_not_recruiting222%
unknown222%
recruiting111%
completed222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9